Lipocalin (ADIPOQ) and 2‐aminonicotinonitrile compounds (w09), both autophagy activators, were reported to drive autophagy genesis in cancer cells through the STK11/LKB1‐AMPK‐ULK1 and EGFR‐RAS‐RAF1‐MAP2K‐MAPK1/3 pathways, respectively, and inhibit the progression of breast cancer and gastric cancer, respectively.172, 173. This evidence concerns the gene STK11 and breast cancer.